Spain’s PLD Space raises €180M to scale satellite launch infrastructure
HQ: ES
Founded: 2011
Series C
Sector: Space
Investment Raised: EUR 180m €
Valuation Remains Undisclosed
Investors: The round included the Spanish Ministry of Science, Innovation and Universities, through the Centre for the Development of Technology and Innovation (CDTI) and its INNVIERTE fund, and the Spanish public funds management company COFIDES, through its FOCO investment fund, and Nazca Capital, via Nazca Aeroespacial y Defensa INNIVERTE I FCR Fund.
RobCo Secures $100 million to Scale Autonomous Industrial Robotics
HQ: DE
Founded: 2020
Series C
Sector: Industrial Automation, Robotics
Investment Raised: USD 100m €
Valuation Remains Undisclosed
Investors: The round was co-led by Lightspeed Venture Partners and Lingotto Innovation, an investment firm owned by Exor, with participation from Sequoia Capital, Greenfield Partners, Kindred Capital, Leitmotif, and The Friedkin Group
Munich-based Tubulis secures €308 million to advance antibody-drug conjugate innovation
HQ: DE
Founded: 2012
Series C
Sector: Biotechnology
Investment Raised: EUR 308m €
Valuation Remains Undisclosed
Investors: Led by Venrock Healthcare Capital Partners, with participation from Wellington Management and Ascenta Capital, alongside existing investors including Nextech Invest, EQT Life Sciences, Frazier Life Sciences, Andera Partners, Deep Track Capital, Bayern Kapital, Fund+, OCCIDENT, Seventure Partners, and HTGF.
Moniepoint tops up Series C with fresh $90m funding
HQ: UK
Founded: 2015
Series C
Sector: FinTech
Investment Raised: USD 90m €
Valuation Remains Undisclosed
Investors: LeapFrog Investments, The initial raise was led by Development Partners International, through the African Development Partners III Fund. Lightrock, Alder Tree Investments, Visa, Proparco, Swedfund, Verod Capital Management, the International Finance Corporation, and Google, through its Africa Investment Fund, also participated in the Series C raise.
Munich-based Tubulis secures €308 million to advance antibody-drug conjugate innovation
HQ: DE
Founded: 2012
Series C
Sector: Biotechnology
Investment Raised: EUR 308m €
Valuation Remains Undisclosed
Investors: Led by Venrock Healthcare Capital Partners, with participation from Wellington Management and Ascenta Capital, alongside existing investors including Nextech Invest, EQT Life Sciences, Frazier Life Sciences, Andera Partners, Deep Track Capital, Bayern Kapital, Fund+, OCCIDENT, Seventure Partners, and HTGF.
n8n Secures $180 Million Series C Funding, Hits $2.5 Billion Valuation to Lead AI-Powered Workflow Automation
HQ: DE
Founded: 2019
Series C
Sector: Artificial Intelligence
Investment Raised: USD 180m €
USD 2.5b
Valuation
Investors: Led by Accel, with support from Meritech, Redpoint, Evantic and Visionaries Club. Corporate investors NVentures (NVIDIA’s venture capital arm) and T.Capital also join the round, with previous backers including Felicis Ventures, Sequoia, Highland Europe and HV Capital making follow-on investments.
Nothing raises $200M Series C to fund AI-driven hardware platform
HQ: UK
Founded: 2020
Series C
Sector: Consumer Electronics
Investment Raised: USD 200m €
USD 1.3b
Valuation
Investors: Led by Tiger Global, included participation from existing investors GV (Google Ventures), Highland Europe, EQT, Latitude Investment Management, I2BF Global Ventures, and Tapestry VC, along with backing from Nikhil Kamath and Qualcomm Ventures
Oxford spinout Ultromics lands $55M to combat hidden heart disease through earlier, smarter diagnosis
HQ: UK
Founded: 2017
Series C
Sector: Artificial Intelligence (AI)
Investment Raised: USD 55m €
Valuation Remains Undisclosed
Investors: Allegis Capital, GV, Legal & General Investment Management (LGIM), Lightrock, Oxford Science Enterprises, The Blue Venture Fund, UCM Ventures, University of Oxford, UPMC Enterprises
